Study population
Patients were derived from 26 centers in the United States of America and Australia, with devices from multiple manufacturers including Medtronic, Abbott Medical, Boston Scientific, and Biotronik. All patients, who transmitted at least one AF episode with specified episode duration during the twelve-month window, were included and classified according to age, CIED-type, estimated minimum CHA